SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Interim Management Statement

26 Jul 2016 07:00

RNS Number : 1780F
Victrex PLC
26 July 2016
 
 

 

 

 

26 July 2016

Victrex plc: Interim Management Statement

'On track for H2 improvement'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its Interim Management Statement for the third quarter (Q3) covering the period 1 April to 30 June 2016.

Performance continued in line with our expectations during Q3. Our core business remains robust, with growth in Aerospace and Automotive, and a steadier performance in Oil & Gas. Our Medical business was in line with the prior year period.

As expected, the Group's overall performance in the quarter was offset by limited volumes in the large Consumer Electronics order during Q3, compared to a strong Q3 2015. As previously communicated, these volumes will be much more back-end loaded into Q4 this year, with second half volumes still expected to be double those in the first half.

For Q3 as a whole, Group revenue was down 6% to £60.6m (Q3 2015: £64.6m), with Group sales volume down 10% to 966 tonnes (Q3 2015: 1,070 tonnes). Excluding Consumer Electronics volumes, overall performance was marginally ahead of the strong Q2.

Cash generation has remained healthy and there have been no significant changes to the Group's financial position since our interim results announcement.

 

Outlook

 

For 2016, our core business remains robust and we continue to focus on cost opportunities. We remain on track for a second half improvement and are comfortable with current expectations for the full year.

 

Variability in end user demand and supply chain dynamics means the Consumer Electronics market continues to offer limited visibility. Our early planning assumptions for 2017 now suggest these volumes will be significantly lower, compared to 2016. We do, however, remain encouraged by medium to longer term growth opportunities within Consumer Electronics and have market-wide development programmes in progress, for both volume and value opportunities. Lower Consumer Electronics volumes in 2017 would improve the Group's sales mix, although it would be less beneficial for operating leverage, reflecting higher fixed costs. Currency for 2017 has now become more supportive, although rates continue to be volatile and hedging is already in place for nearly two-thirds of our FY17 financial year.

 

Victrex remains in a good position for the medium to longer term. The Group has a strategy to further increase our differentiation, a strong pipeline of potentially game-changing projects and a highly cash generative business model.

 

 

 

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 7809 595831

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

 

Teneo Strategy:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the Automotive, Aerospace, Energy, Electronics and Medical markets. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we deliver leading edge solutions to shape future performance for our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKXSADSKEFF
Date   Source Headline
30th Nov 20161:30 pmRNSTotal Voting Rights
17th Nov 20162:19 pmRNSDirector/PDMR Shareholding
10th Nov 201611:11 amRNSAdditional Listing
31st Oct 20162:39 pmRNSTotal Voting Rights
18th Oct 20162:10 pmRNSDirector/PDMR Shareholding
11th Oct 20167:00 amRNSTrading Statement
30th Sep 20161:11 pmRNSTotal Voting Rights
19th Sep 20164:28 pmRNSDirector/PDMR Shareholding
19th Sep 20163:18 pmRNSHolding(s) in Company
31st Aug 20169:28 amRNSTotal Voting Rights
17th Aug 20163:46 pmRNSDirector/PDMR Shareholding
29th Jul 20162:47 pmRNSTotal Voting Rights
28th Jul 20162:57 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSInterim Management Statement
19th Jul 20164:34 pmRNSDirector/PDMR Shareholding
30th Jun 201610:00 amRNSTotal Voting Rights
17th Jun 20163:56 pmRNSDirector/PDMR Shareholding
14th Jun 20164:42 pmRNSHolding(s) in Company
14th Jun 20164:24 pmRNSHolding(s) in Company
1st Jun 20169:02 amRNSBlock listing Interim Review
31st May 201611:42 amRNSTotal Voting Rights
26th May 20164:26 pmRNSHolding(s) in Company
17th May 20164:11 pmRNSDirector/PDMR Shareholding
16th May 20167:00 amRNSHalf-year Report
3rd May 20163:27 pmRNSHolding(s) in Company
3rd May 20163:15 pmRNSHolding(s) in Company
3rd May 20163:00 pmRNSHolding(s) in Company
29th Apr 201610:00 amRNSTotal Voting Rights
28th Apr 20167:00 amRNSResolution of US FTC inquiry
21st Apr 20167:00 amRNSDirector Declaration
19th Apr 201611:07 amRNSDirector/PDMR Shareholding
7th Apr 20167:00 amRNSTrading Statement
31st Mar 20162:51 pmRNSTotal Voting Rights
31st Mar 20161:45 pmRNSTotal Voting Rights
17th Mar 201610:15 amRNSDirector/PDMR Shareholding
1st Mar 20165:00 pmRNSDirector/PDMR Shareholding
29th Feb 20162:18 pmRNSTotal Voting Rights
26th Feb 20163:09 pmRNSHome Member State
17th Feb 201611:27 amRNSDirector/PDMR Shareholding
10th Feb 20163:55 pmRNSResult of AGM
10th Feb 20167:00 amRNSAGM Statement
9th Feb 20164:44 pmRNSHolding(s) in Company
5th Feb 20161:38 pmRNSGrant of Options
29th Jan 20169:27 amRNSTotal Voting Rights
19th Jan 201611:39 amRNSDirector/PDMR Shareholding
19th Jan 201610:08 amRNSDirector Declaration
5th Jan 201612:00 pmRNSAnnual Financial Report
31st Dec 201510:00 amRNSTotal Voting Rights
17th Dec 20154:23 pmRNSHolding(s) in Company
17th Dec 20153:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.